Korean Ministry of Culture

Saudi Aramco GIITS 2023: Korean IIoT and Digital Solution Companies Participate

Retrieved on: 
Monday, November 20, 2023
IOT (Internet of Things), Technology, Oil, Gas, Energy, Software, Networks, Internet, Cloud, Cloud computing, Korean Ministry of Culture, Global Industrial, Access All Areas Tour, Multimedia, Industrial, SME, Mobilio, Unicorn, Government, Video game, Industrial internet of things

View the full release here: https://www.businesswire.com/news/home/20231119310025/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231119310025/en/
    Cloud Service and IIoT Digital Solution of All Areas (Logo: MEGAZONECLOUD)
    MEGAZONECLOUD is recognized as a cloud innovator and the first Unicorn company in the Korean Cloud industry.
  • Korean companies participating in GIITS 2023 include MEGAZONECLOUD , Mobilio , BizData , Spacebank , and FutureMain .
  • This is a global Industrial Internet of Things (IIoT) event in which companies from various industries and IIoT enterprises worldwide participate.
  • MEGAZONECLOUD and KOSA have selected Korean companies participating in GIITS 2023 based on professional advice from experts in IIoT, cloud computing, and software industry.

SISTECH Moves into Global Stage in City-scale 3D-Model Service Sector

Retrieved on: 
Monday, November 27, 2023
Korean Ministry of Culture, Google Maps, Commercial, Multimedia, Microsoft, 3D, Czech Republic, GCS, VIP, Transport, Pocs, Video game, Surveying

SEOUL, South Korea, Nov. 27, 2023 /PRNewswire/ -- Korea's SISTECH has officially launched its global expansion bid in the City-scale 3D-model service sector.

Key Points: 
  • SEOUL, South Korea, Nov. 27, 2023 /PRNewswire/ -- Korea's SISTECH has officially launched its global expansion bid in the City-scale 3D-model service sector.
  • SISTECH started as a specialized drone manufacturing company for spatial information in 2015.
  • Currently, it is deploying City-scale broadband (100 square kilometers or more) 3D-model services using its self-developed fixed-wing drone K-Mapper.
  • We plan to conduct PoCs with Google Maps soon to apply our high-precision drone map service to Google as well."

Rznomics Inc. Secures Fast Track Designation from the U.S. FDA for RZ-001

Retrieved on: 
Friday, November 10, 2023
Priority review, Korean Ministry of Culture, Safety, MFDS, Cancer, GBM, Clinical trial, Mortality, Fast track (FDA), Patient, Reverse transcriptase, Central nervous system, FDA, Survival rate, Sympathetic nervous system, Messenger, Therapy, Accelerated approval (FDA), RNA, Pharmaceutical industry, Medical device, Food, Glioblastoma

Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and address unmet medical needs, thus enabling drugs to reach patients sooner.

Key Points: 
  • Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and address unmet medical needs, thus enabling drugs to reach patients sooner.
  • If relevant criteria are met, the drug with Fast Track Designation may also be eligible for Accelerated Approval and Priority Review.
  • GBM is known as the most malignant tumor in Central Nervous system with high mortality rate but lacks effective therapies.
  • "We are proud to receive Fast Track Designation from the FDA," said Dr. Seong-Wook Lee, Chief Executive Officer of Rznomics.

Rznomics Inc. Secures Fast Track Designation from the U.S. FDA for RZ-001

Retrieved on: 
Friday, November 10, 2023
Priority review, Korean Ministry of Culture, Safety, MFDS, Cancer, GBM, Clinical trial, Mortality, Fast track (FDA), Patient, Reverse transcriptase, Central nervous system, FDA, Survival rate, Sympathetic nervous system, Messenger, Therapy, Accelerated approval (FDA), RNA, Pharmaceutical industry, Medical device, Food, Glioblastoma

Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and address unmet medical needs, thus enabling drugs to reach patients sooner.

Key Points: 
  • Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and address unmet medical needs, thus enabling drugs to reach patients sooner.
  • If relevant criteria are met, the drug with Fast Track Designation may also be eligible for Accelerated Approval and Priority Review.
  • GBM is known as the most malignant tumor in Central Nervous system with high mortality rate but lacks effective therapies.
  • "We are proud to receive Fast Track Designation from the FDA," said Dr. Seong-Wook Lee, Chief Executive Officer of Rznomics.

The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval

Retrieved on: 
Monday, November 6, 2023
MFDS, Korea Disease Control and Prevention Agency, KDCA, Incidence, Infection, Vaccine, Bioterrorism, Bacillus anthracis, Research, Cell, Protein, Volunteering, Development, Korean Ministry of Culture, Disulfiram-like drug, Phase, Antibody, Marketing, Medicine, Public, Anthrax, Safety, Public and private bills, DNA, Food

YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ -- GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of "GC1109", an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), to the Korean Ministry of Food and Drug Safety (MFDS).

Key Points: 
  • YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ -- GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of "GC1109", an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), to the Korean Ministry of Food and Drug Safety (MFDS).
  • If approved, "GC1109" will be the world's first recombinant anthrax vaccine.
  • In order to prepare against potential bioterrorism and consequent national crisis, GC Biopharma, under the research project supported by KDCA, has been working on developing a recombinant vaccine for anthrax since 2002.
  • GC Biopharma stated, "We believe in the significance of our journey to localize the anthrax vaccine in terms of securing vaccine sovereignty, while promoting public health and national security.

TelePIX, South Korean Startup, Signs Deal to Provide Earth Observation Imagery Data from its BlueBon Satellite

Retrieved on: 
Wednesday, November 1, 2023
Carbon, Data analysis, Korea Aerospace Research Institute, Observation, Software, Multimedia, Korean Ministry of Culture, Methane, IAC, Polish Space Agency, International Astronautical Congress, Economic development, Blue carbon, ICT, Greenhouse, SatRevolution, Climate change, Surveying, Science

This groundbreaking deal marks the first time that South Korea is exporting observational imagery data from its proprietary satellite.

Key Points: 
  • This groundbreaking deal marks the first time that South Korea is exporting observational imagery data from its proprietary satellite.
  • The core of this agreement is TelePIX's commitment to provide satellite imagery data, specifically focusing on "Blue Carbon" from its in-house designed and built satellite, the "BlueBon."
  • This compact 6U-class nanosatellite is scheduled to launch in 2024, delivering 3.8-meter optical observation satellite imagery data.
  • Founded in 2019, TelePIX specializes in developing optical payloads for Earth observation and software for satellite imagery data analysis.

Mo[+] Plus: Composite Product for Hair Care by Mirae Wellcare

Retrieved on: 
Wednesday, October 25, 2023
Vitamins, Supplements, Fitness & Nutrition, Health, Other Health, Food safety, Hair loss, HACCP, National Health Service, Certification, Health Insurance Review and Assessment Service, Accreditation, Korean Ministry of Culture, Tablet, Hair, Biotin, Assessment, Patient, Alopecia areata, Dietary supplement, Food

Mirae Wellcare, a South Korean health food provider, introduces Mo[+] Plus, a hair care composite product that promotes healthy hair.

Key Points: 
  • Mirae Wellcare, a South Korean health food provider, introduces Mo[+] Plus, a hair care composite product that promotes healthy hair.
  • Biotin, in particular, is an essential nutrient for hair strengthening, organization, and production.
  • Prior to the manufacturing process, all raw materials of Mo[+] Plus are subject to metal contamination and E. coli testing.
  • In appreciation of its safe production procedure, the product acquired HACCP accreditation, a food safety management certification.

GC Cell Joins U.S Cancer Moonshot Project

Retrieved on: 
Wednesday, October 25, 2023
Knowledge, Cancer Moonshot, Dime, AstraZeneca, H. Lee Moffitt Cancer Center & Research Institute, Multi, Life, Mortality, Yale Physician Associate Program, Monroe Dunaway Anderson, Dana–Farber Cancer Institute, CDMO, Research, CGT, Korean Ministry of Culture, Genomics, Liver cancer, Intel, NK, Partnership, Natural killer cell, Cancer, AI, Johnson & Johnson, Patient, Mayo Clinic, Medical imaging, Pharmaceutical industry, Vaccine, Food, Takeda, Amazon, Oracle

YONGIN, South Korea, Oct. 24, 2023 /PRNewswire/ -- GC Cell, led by CEO James Park, has announced its participation in CancerX, part of the U.S. Cancer Moonshot project. The Cancer Moonshot, an initiative by the Biden administration, aims to reduce cancer patient mortality rates by over 50% over the next 25 years. In February of this year, CancerX, a public-private collaboration led by the Moffitt Cancer Center and the Digital Medicine Society, was established to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot.

Key Points: 
  • YONGIN, South Korea, Oct. 24, 2023 /PRNewswire/ -- GC Cell, led by CEO James Park, has announced its participation in CancerX, part of the U.S. Cancer Moonshot project.
  • The Cancer Moonshot, an initiative by the Biden administration, aims to reduce cancer patient mortality rates by over 50% over the next 25 years.
  • In February of this year, CancerX, a public-private collaboration led by the Moffitt Cancer Center and the Digital Medicine Society, was established to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot.
  • Through Cancer Moonshot participation, GC Cell aims to highlight the importance and potential of cell therapy in cancer treatment.

VUNO's First AI-based Prospective Study Results Published in Critical Care

Retrieved on: 
Monday, September 18, 2023
Blood pressure, Real, Dong-a University Hospital, Cardiac arrest, Cohort (statistics), Bed, Respiratory rate, National Early Music Association, MFDS, MEWS, Research, Multimedia, AUROC, RWD, Real World, Thermoregulation, Korean Ministry of Culture, Seoul National University Hospital, Vital signs, Patient, Patient safety, UIT, NEWS, Trial of the century, Heart rate, Medical device, Pharmaceutical industry, Nursing, Critical care, Food

VUNO announced that the multicenter clinical study paper, which confirms the clinical validity of VUNO Med®-DeepCARS™ through its initial prospective research, has been published in "Critical Care," a leading international journal in intensive care medicine.

Key Points: 
  • VUNO announced that the multicenter clinical study paper, which confirms the clinical validity of VUNO Med®-DeepCARS™ through its initial prospective research, has been published in "Critical Care," a leading international journal in intensive care medicine.
  • In the study published in Critical Care, the VUNO research team conducted a multicenter study using patient data from general wards at four tertiary medical institutions: Seoul National University Hospital, Bundang Seoul National University Hospital, Inha University Hospital, and Dong-A University Hospital, each with varying sizes, locations, and medical environments.
  • The study found that the predictive performance of VUNO Med®-DeepCARS™ had an AUROC score of 0.869, outperforming traditional methods (NEWS 0.767, MEWS 0.756).
  • In this study, VUNO Med®-DeepCARS™ displayed exceptional predictive abilities and adaptability in identifying high-risk patients, even in its first prospective research.

Korea University and International ESG Association (IESGA) Host a Special Meeting About the Sustainable Biochar Market

Retrieved on: 
Thursday, September 14, 2023
International Environmental Design Contest, University, Department of Primary Industries (New South Wales), APRU, Clarivate, Korea University, Sōka University, CJ, Livestock, Research, Carbon, MAFRA, Government, Ministry of Agriculture, Food and Rural Affairs (South Korea), Korean Ministry of Culture, Business administration, Informal economy, Bay, Manure, ESG, Environment, Food, Management, Agriculture

SEOUL, Sept. 14, 2023 /PRNewswire/ -- Korea recently witnessed a significant meeting aimed at fostering a strong and sustainable biochar market. The Association of Pacific Rim Universities Sustainable Waste Management Program (APRU SWM), the International Environmental, Social, and Governance (ESG) Association (IESGA), and the Korea University ESG Research Institute recently collaborated with the Korean Ministry of Agriculture, Food and Rural Affairs (MAFRA) for a special meeting that brought together experts from academia, industry, and government.

Key Points: 
  • SEOUL, Sept. 14, 2023 /PRNewswire/ -- Korea recently witnessed a significant meeting aimed at fostering a strong and sustainable biochar market.
  • Accompanying him was Prof. Jay Hyuk Rhee, director of the Korea University ESG Research Institute and also the president of IESGA.
  • The focal point of the meeting was centered on the theme, "Journey Toward a Sustainable Biochar Market across Korea.
  • MAFRA will work with international governments, academic institutions, and industries to conduct research, develop eco-friendly biochar production technologies, and gather feedback for a sustainable biochar market in Korea.